New centre for radiopharmaceutical development at
University Hospital Munich
13 August 2011
Ion Beam Applications (IBA) S.A., has announced that its
German partner, PET Net GmbH, has reached an agreement with the
University Hospital of Munich to install a state-of-the-art centre for
radio-pharmaceutical development and production.
This agreement highlights IBA’s commitment to expanding in nuclear
medicine markets through key partnerships in parallel to its organic
growth.
The project will provide €15 million in financing to build a 1050
m² state-of-the-art center for radiopharmaceutical development and
production that will focus on Positron Emission Tomography (PET), a
non-invasive method used in molecular imaging to visualize
biological processes for the early detection and real-time
monitoring of cancer and other diseases.
The partnership will focus on the development of new PET
radiopharmaceuticals and the production of existing diagnostic
tracers. The facility will be built near the existing nuclear
medicine clinical center at the Grosshardern University Hospital,
currently one of the leading PET examination clinics in Europe.
“Through this collaboration, PET Net has achieved a major step
forward in expanding its radiopharmaceuticals network in Germany,
and we are delighted to have them as our German partner,” said
François Labarre, president, IBA Molecular Europe. “Not only are
plans for this new center testimony to PET Net’s strength in the
German market and its potential for growth, they also confirm that
IBA is committed to partnering with companies that we have
identified as industry leaders.”
In April 2011, IBA announced that it had made a 25.2% minority
stake investment in PET Net, a provider of PET radiopharmaceuticals
to nuclear medicine facilities in Germany, in order to strengthen
its PET infrastructure in Germany with a local partner. PET Net is
experienced in the management of centers for the production of
radiopharmaceuticals, regulatory affairs and manufacturing licensees
and currently manages two production sites in Erlangen and
Regensburg, Germany.
Source: IBA Group